NCCN 2018 Nursing Program Webinar Series - Management of Hypersensitivity Reactions to Systemic Therapy

June 26, 2018

Infusion-related HSR to systemic therapy is a serious adverse effect that significantly impacts disease management, quality of life, and life expectancy. Careful assessment of patients prior to initiating systemic therapy would enable the identification of patients at higher risk for HSR. A thorough understanding of the pathophysiology of different types of infusion-related HSR is critical for the early recognition of signs and symptoms as well as implementation of effective prophylactic measures to minimize the risk of HSR. Nurse practitioners require ongoing education that would provide expert guidance necessary for the optimal management of infusion-related HSR without compromising the curative potential of anticancer therapy.

Target Audience

This educational program is designed to meet the educational needs of oncology nurses who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Discuss the pathophysiology of the different types of infusion-related HSR to chemotherapeutic agents and MABs.
  • Review the strategies used for the prevention and treatment of infusion-related HSR to systemic therapy.
  • Develop an evidence-based treatment plan for the management of infusion-related HSR in patients receiving systemic therapy.
Additional information
Supporters: 

Supported by educational grants from:

  • Celgene Corporation
  • Novartis
  • Pfizer

Supported by an independent educational grant from Incyte.
Supported by a medical education grant from Exelixis, Inc.
Supported by an unrestricted educational grant from Gilead Sciences, Medical Affairs

Course summary
Available credit: 
  • 1.00 ANCC contact hours
  • 1.00 Participation
Course opens: 
05/22/2018
Course expires: 
08/26/2018
Event starts: 
06/26/2018 - 12:00pm
Event ends: 
06/26/2018 - 1:00pm
Cost:
$0.00

Barbara Rogers, CRNP, MN, AOCN, ANP-BC
Fox Chase Cancer Center

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 1.0 contact hour.

Available Credit

  • 1.00 ANCC contact hours
  • 1.00 Participation

Accreditation Period

Course opens: 
05/22/2018
Course expires: 
08/26/2018

Price

Cost:
$0.00
Please login or register to take this course.

Click the Take Course button to register for this live webinar.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing